Nancy Krebs
Concepts (707)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Zinc | 110 | 2025 | 292 | 16.280 |
Why?
| Infant Nutritional Physiological Phenomena | 40 | 2025 | 137 | 9.530 |
Why?
| Dietary Supplements | 55 | 2025 | 531 | 7.830 |
Why?
| Nutritional Status | 41 | 2024 | 326 | 6.170 |
Why?
| Milk, Human | 33 | 2023 | 149 | 5.800 |
Why?
| Developing Countries | 76 | 2025 | 286 | 5.730 |
Why?
| Breast Feeding | 51 | 2024 | 422 | 5.560 |
Why?
| Micronutrients | 23 | 2025 | 88 | 5.240 |
Why?
| Maternal Nutritional Physiological Phenomena | 15 | 2024 | 169 | 5.220 |
Why?
| Diet | 61 | 2025 | 1204 | 5.180 |
Why?
| Infant Food | 25 | 2025 | 65 | 4.300 |
Why?
| Intestinal Absorption | 37 | 2022 | 99 | 4.120 |
Why?
| Meat | 13 | 2021 | 93 | 4.060 |
Why?
| Infant | 153 | 2025 | 9001 | 3.660 |
Why?
| Child Development | 21 | 2024 | 455 | 3.600 |
Why?
| Premature Birth | 23 | 2023 | 310 | 3.430 |
Why?
| Iron | 20 | 2025 | 282 | 3.370 |
Why?
| Pregnancy Outcome | 30 | 2024 | 390 | 3.320 |
Why?
| Nutritional Requirements | 25 | 2019 | 77 | 3.240 |
Why?
| Infant Mortality | 36 | 2023 | 104 | 3.030 |
Why?
| Infant, Newborn | 115 | 2025 | 5740 | 3.030 |
Why?
| Preconception Care | 11 | 2025 | 40 | 2.970 |
Why?
| Pregnancy | 129 | 2025 | 6373 | 2.900 |
Why?
| Phytic Acid | 19 | 2017 | 43 | 2.850 |
Why?
| Growth Disorders | 12 | 2022 | 80 | 2.640 |
Why?
| Anemia, Iron-Deficiency | 10 | 2025 | 57 | 2.610 |
Why?
| Iron, Dietary | 9 | 2019 | 21 | 2.510 |
Why?
| Infant Formula | 11 | 2023 | 74 | 2.430 |
Why?
| Perinatal Death | 13 | 2023 | 22 | 2.390 |
Why?
| Guatemala | 37 | 2024 | 311 | 2.350 |
Why?
| Stillbirth | 25 | 2023 | 61 | 2.340 |
Why?
| Child Health | 20 | 2023 | 146 | 2.310 |
Why?
| Female | 257 | 2025 | 68268 | 2.220 |
Why?
| Prenatal Care | 23 | 2025 | 275 | 2.200 |
Why?
| Food, Fortified | 18 | 2023 | 37 | 2.150 |
Why?
| Poverty | 13 | 2023 | 497 | 2.100 |
Why?
| Humans | 333 | 2025 | 128499 | 2.070 |
Why?
| Obesity, Morbid | 7 | 2021 | 240 | 2.010 |
Why?
| Obesity | 24 | 2024 | 2864 | 1.890 |
Why?
| Homeostasis | 21 | 2015 | 606 | 1.890 |
Why?
| Dairy Products | 3 | 2021 | 36 | 1.880 |
Why?
| Cesarean Section | 8 | 2021 | 182 | 1.870 |
Why?
| Infant Health | 10 | 2023 | 24 | 1.850 |
Why?
| Lactation | 15 | 2024 | 170 | 1.830 |
Why?
| Body Mass Index | 23 | 2023 | 2263 | 1.780 |
Why?
| Fetal Development | 6 | 2025 | 284 | 1.780 |
Why?
| Pakistan | 31 | 2024 | 75 | 1.760 |
Why?
| Feces | 25 | 2023 | 442 | 1.730 |
Why?
| Gastric Bypass | 6 | 2019 | 107 | 1.730 |
Why?
| Trace Elements | 13 | 2022 | 47 | 1.680 |
Why?
| Delivery, Obstetric | 19 | 2025 | 137 | 1.670 |
Why?
| Mothers | 13 | 2024 | 729 | 1.600 |
Why?
| Maternal Mortality | 18 | 2025 | 41 | 1.530 |
Why?
| Pregnancy Complications | 16 | 2024 | 491 | 1.510 |
Why?
| Dietary Proteins | 10 | 2025 | 128 | 1.500 |
Why?
| Birth Weight | 22 | 2024 | 499 | 1.490 |
Why?
| Energy Intake | 11 | 2025 | 454 | 1.400 |
Why?
| Infant, Small for Gestational Age | 6 | 2021 | 84 | 1.380 |
Why?
| Growth | 7 | 2020 | 58 | 1.340 |
Why?
| Maternal Health | 6 | 2023 | 46 | 1.300 |
Why?
| Pregnancy Complications, Infectious | 8 | 2025 | 364 | 1.280 |
Why?
| Zea mays | 12 | 2017 | 41 | 1.270 |
Why?
| Infant, Premature | 9 | 2023 | 538 | 1.270 |
Why?
| Adult | 110 | 2025 | 35302 | 1.260 |
Why?
| Anthropometry | 13 | 2024 | 204 | 1.250 |
Why?
| Gastrointestinal Microbiome | 8 | 2025 | 641 | 1.240 |
Why?
| Child | 71 | 2024 | 20805 | 1.230 |
Why?
| Child, Preschool | 52 | 2025 | 10487 | 1.210 |
Why?
| Gastrectomy | 3 | 2021 | 99 | 1.200 |
Why?
| Anemia | 8 | 2025 | 160 | 1.190 |
Why?
| Gestational Age | 15 | 2023 | 871 | 1.180 |
Why?
| Zinc Isotopes | 22 | 2011 | 22 | 1.180 |
Why?
| Child Nutritional Physiological Phenomena | 9 | 2019 | 104 | 1.180 |
Why?
| Rural Population | 18 | 2022 | 517 | 1.150 |
Why?
| Malnutrition | 4 | 2023 | 79 | 1.140 |
Why?
| Feeding Behavior | 12 | 2023 | 619 | 1.120 |
Why?
| Infant, Low Birth Weight | 13 | 2024 | 135 | 1.110 |
Why?
| Pre-Eclampsia | 5 | 2023 | 185 | 1.110 |
Why?
| Prospective Studies | 49 | 2024 | 7069 | 1.080 |
Why?
| Biological Availability | 22 | 2022 | 131 | 1.070 |
Why?
| Registries | 27 | 2023 | 1883 | 1.050 |
Why?
| Nutritional Sciences | 5 | 2019 | 41 | 1.020 |
Why?
| Nutrition Assessment | 4 | 2017 | 85 | 1.020 |
Why?
| Zambia | 18 | 2024 | 55 | 1.010 |
Why?
| Biomarkers | 21 | 2024 | 3893 | 1.000 |
Why?
| Male | 117 | 2025 | 63045 | 1.000 |
Why?
| Food | 3 | 2020 | 154 | 1.000 |
Why?
| Body Composition | 9 | 2023 | 644 | 0.990 |
Why?
| Azithromycin | 6 | 2025 | 92 | 0.970 |
Why?
| Weaning | 6 | 2024 | 48 | 0.930 |
Why?
| Birth Intervals | 2 | 2021 | 21 | 0.910 |
Why?
| Perinatal Mortality | 10 | 2022 | 12 | 0.910 |
Why?
| Vaginal Birth after Cesarean | 2 | 2021 | 25 | 0.900 |
Why?
| Powders | 10 | 2025 | 43 | 0.870 |
Why?
| Young Adult | 50 | 2024 | 12349 | 0.870 |
Why?
| Postpartum Period | 6 | 2024 | 331 | 0.870 |
Why?
| Congenital Abnormalities | 3 | 2020 | 73 | 0.860 |
Why?
| India | 16 | 2024 | 170 | 0.850 |
Why?
| Premenopause | 3 | 2021 | 121 | 0.840 |
Why?
| Democratic Republic of the Congo | 13 | 2024 | 25 | 0.830 |
Why?
| Anastomosis, Roux-en-Y | 2 | 2021 | 27 | 0.820 |
Why?
| Education, Medical | 4 | 2019 | 244 | 0.820 |
Why?
| Maternal Health Services | 6 | 2019 | 95 | 0.820 |
Why?
| Double-Blind Method | 18 | 2025 | 1856 | 0.790 |
Why?
| Amino Acids, Branched-Chain | 2 | 2021 | 36 | 0.790 |
Why?
| Obstetric Labor Complications | 6 | 2020 | 29 | 0.780 |
Why?
| Inflammation | 6 | 2022 | 2666 | 0.780 |
Why?
| Overweight | 7 | 2023 | 523 | 0.780 |
Why?
| Women's Health | 13 | 2023 | 361 | 0.780 |
Why?
| Vegetables | 2 | 2022 | 147 | 0.770 |
Why?
| Vitamins | 3 | 2023 | 174 | 0.760 |
Why?
| Edible Grain | 7 | 2014 | 48 | 0.750 |
Why?
| Cesarean Section, Repeat | 1 | 2021 | 11 | 0.750 |
Why?
| Weight Reduction Programs | 2 | 2013 | 111 | 0.740 |
Why?
| Body Height | 6 | 2022 | 193 | 0.730 |
Why?
| Nutritive Value | 3 | 2024 | 36 | 0.710 |
Why?
| Pregnant Women | 6 | 2023 | 115 | 0.700 |
Why?
| Models, Biological | 9 | 2016 | 1698 | 0.700 |
Why?
| Deficiency Diseases | 6 | 2019 | 10 | 0.690 |
Why?
| Weight Gain | 8 | 2023 | 504 | 0.680 |
Why?
| Ultrasonography, Prenatal | 6 | 2020 | 270 | 0.670 |
Why?
| Dietary Approaches To Stop Hypertension | 1 | 2020 | 12 | 0.670 |
Why?
| Milk Banks | 1 | 2019 | 1 | 0.660 |
Why?
| Recommended Dietary Allowances | 3 | 2018 | 19 | 0.660 |
Why?
| Health Education | 4 | 2018 | 332 | 0.650 |
Why?
| Adolescent | 46 | 2023 | 20304 | 0.650 |
Why?
| Malabsorption Syndromes | 1 | 2019 | 17 | 0.640 |
Why?
| Dietary Fats | 2 | 2020 | 301 | 0.640 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2019 | 9 | 0.630 |
Why?
| Iron Metabolism Disorders | 2 | 2015 | 4 | 0.630 |
Why?
| Maternal Death | 4 | 2020 | 11 | 0.620 |
Why?
| Developed Countries | 2 | 2015 | 33 | 0.620 |
Why?
| Bangladesh | 8 | 2025 | 45 | 0.610 |
Why?
| Metabolomics | 2 | 2021 | 602 | 0.610 |
Why?
| Hemoglobins | 7 | 2025 | 337 | 0.610 |
Why?
| Organic Chemicals | 1 | 2020 | 128 | 0.600 |
Why?
| Longitudinal Studies | 19 | 2023 | 2710 | 0.600 |
Why?
| Malaria | 1 | 2019 | 59 | 0.600 |
Why?
| Quality Assurance, Health Care | 1 | 2020 | 316 | 0.600 |
Why?
| Nutrition Therapy | 2 | 2019 | 31 | 0.600 |
Why?
| Avitaminosis | 1 | 2018 | 7 | 0.600 |
Why?
| Parity | 8 | 2023 | 120 | 0.590 |
Why?
| RNA, Ribosomal, 16S | 2 | 2017 | 522 | 0.580 |
Why?
| Enteritis | 1 | 2019 | 93 | 0.580 |
Why?
| Sepsis | 4 | 2025 | 569 | 0.580 |
Why?
| Kenya | 11 | 2024 | 107 | 0.570 |
Why?
| Body Size | 6 | 2019 | 102 | 0.570 |
Why?
| Weight Loss | 2 | 2013 | 727 | 0.560 |
Why?
| Anti-Bacterial Agents | 5 | 2025 | 1705 | 0.560 |
Why?
| Diarrhea | 5 | 2022 | 180 | 0.550 |
Why?
| Insulin | 7 | 2021 | 2316 | 0.550 |
Why?
| Body Weight | 13 | 2019 | 933 | 0.550 |
Why?
| Prevalence | 13 | 2025 | 2553 | 0.540 |
Why?
| Metabolome | 1 | 2020 | 320 | 0.530 |
Why?
| Leptin | 5 | 2018 | 218 | 0.520 |
Why?
| Vitamin E | 1 | 2016 | 120 | 0.510 |
Why?
| Child Nutrition Sciences | 1 | 2015 | 8 | 0.500 |
Why?
| Cross-Sectional Studies | 25 | 2023 | 5045 | 0.480 |
Why?
| Gastrointestinal Absorption | 1 | 2014 | 5 | 0.470 |
Why?
| Global Health | 9 | 2021 | 330 | 0.470 |
Why?
| Starch | 1 | 2015 | 22 | 0.470 |
Why?
| Pregnancy Trimester, First | 7 | 2023 | 138 | 0.470 |
Why?
| Brain | 2 | 2017 | 2624 | 0.470 |
Why?
| Nutrition Policy | 6 | 2017 | 56 | 0.470 |
Why?
| Prenatal Nutritional Physiological Phenomena | 5 | 2024 | 59 | 0.460 |
Why?
| Aging | 6 | 2018 | 1755 | 0.460 |
Why?
| Cohort Studies | 14 | 2021 | 5402 | 0.460 |
Why?
| Risk Factors | 26 | 2025 | 9737 | 0.460 |
Why?
| Calcium | 5 | 2022 | 1183 | 0.450 |
Why?
| Health Promotion | 4 | 2023 | 716 | 0.450 |
Why?
| Infant, Premature, Diseases | 1 | 2015 | 93 | 0.450 |
Why?
| Age Factors | 9 | 2015 | 3122 | 0.450 |
Why?
| Adiposity | 3 | 2018 | 504 | 0.440 |
Why?
| Pediatrics | 6 | 2018 | 1050 | 0.440 |
Why?
| Socioeconomic Factors | 13 | 2024 | 1212 | 0.430 |
Why?
| Calcium, Dietary | 5 | 2022 | 56 | 0.430 |
Why?
| Educational Status | 11 | 2022 | 470 | 0.430 |
Why?
| Diet, Mediterranean | 2 | 2024 | 29 | 0.430 |
Why?
| Income | 9 | 2023 | 189 | 0.420 |
Why?
| Regression Analysis | 10 | 2016 | 982 | 0.420 |
Why?
| Dysprosium | 2 | 2010 | 2 | 0.410 |
Why?
| Aspirin | 6 | 2024 | 378 | 0.410 |
Why?
| Randomized Controlled Trials as Topic | 9 | 2025 | 1358 | 0.410 |
Why?
| Antioxidants | 1 | 2016 | 545 | 0.410 |
Why?
| Neurodevelopmental Disorders | 3 | 2023 | 155 | 0.410 |
Why?
| Flour | 4 | 2015 | 6 | 0.400 |
Why?
| Hypertension, Pregnancy-Induced | 2 | 2023 | 68 | 0.400 |
Why?
| Occupational Health Services | 1 | 2012 | 31 | 0.400 |
Why?
| Pregnancy Trimester, Third | 3 | 2017 | 108 | 0.390 |
Why?
| Triticum | 2 | 2009 | 11 | 0.390 |
Why?
| Intestinal Mucosa | 7 | 2018 | 581 | 0.390 |
Why?
| Metagenome | 1 | 2013 | 140 | 0.380 |
Why?
| Heme | 1 | 2012 | 76 | 0.380 |
Why?
| Dietary Carbohydrates | 2 | 2010 | 150 | 0.380 |
Why?
| Glucocorticoids | 4 | 2016 | 573 | 0.380 |
Why?
| Protein Hydrolysates | 2 | 2002 | 6 | 0.370 |
Why?
| Caseins | 2 | 2002 | 18 | 0.370 |
Why?
| Insulin-Like Growth Factor I | 3 | 2021 | 307 | 0.370 |
Why?
| Maternal Age | 12 | 2020 | 123 | 0.370 |
Why?
| Social Class | 3 | 2022 | 258 | 0.370 |
Why?
| Gastrointestinal Tract | 1 | 2013 | 183 | 0.350 |
Why?
| Labor, Obstetric | 2 | 2021 | 58 | 0.350 |
Why?
| Workplace | 1 | 2012 | 246 | 0.340 |
Why?
| Maternal-Child Health Services | 3 | 2019 | 12 | 0.340 |
Why?
| Wasting Syndrome | 1 | 2010 | 12 | 0.340 |
Why?
| Failure to Thrive | 3 | 2009 | 29 | 0.340 |
Why?
| Plant Preparations | 1 | 2010 | 31 | 0.340 |
Why?
| Cardiovascular Diseases | 4 | 2024 | 2001 | 0.330 |
Why?
| Biological Transport | 3 | 2021 | 396 | 0.330 |
Why?
| Time Factors | 9 | 2021 | 6506 | 0.330 |
Why?
| Nutritional Physiological Phenomena | 4 | 2022 | 52 | 0.330 |
Why?
| Nutrition Surveys | 1 | 2011 | 261 | 0.320 |
Why?
| Absorption | 11 | 2013 | 57 | 0.320 |
Why?
| Quality Indicators, Health Care | 1 | 2012 | 296 | 0.310 |
Why?
| Staining and Labeling | 1 | 2009 | 137 | 0.310 |
Why?
| Lipids | 2 | 2024 | 621 | 0.310 |
Why?
| Fetus | 4 | 2021 | 765 | 0.310 |
Why?
| Medically Underserved Area | 3 | 2018 | 84 | 0.300 |
Why?
| Patient Safety | 1 | 2012 | 286 | 0.300 |
Why?
| Cross-Over Studies | 6 | 2020 | 509 | 0.300 |
Why?
| Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| Diet Records | 5 | 2014 | 80 | 0.290 |
Why?
| Seafood | 2 | 2025 | 27 | 0.290 |
Why?
| Practice Guidelines as Topic | 4 | 2016 | 1490 | 0.280 |
Why?
| Logistic Models | 4 | 2021 | 1980 | 0.280 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2023 | 1276 | 0.280 |
Why?
| Antibiotic Prophylaxis | 2 | 2025 | 101 | 0.280 |
Why?
| Pediatric Obesity | 3 | 2023 | 570 | 0.270 |
Why?
| Cytokines | 3 | 2021 | 1994 | 0.270 |
Why?
| Administration, Oral | 7 | 2023 | 767 | 0.270 |
Why?
| Diabetes, Gestational | 2 | 2021 | 308 | 0.270 |
Why?
| Urinalysis | 5 | 2020 | 70 | 0.270 |
Why?
| Referral and Consultation | 3 | 2019 | 728 | 0.260 |
Why?
| Adiponectin | 2 | 2018 | 234 | 0.260 |
Why?
| Follow-Up Studies | 7 | 2024 | 4874 | 0.260 |
Why?
| Communicable Diseases | 2 | 2023 | 145 | 0.260 |
Why?
| Health Personnel | 3 | 2023 | 649 | 0.260 |
Why?
| Folic Acid | 3 | 2023 | 184 | 0.250 |
Why?
| Cause of Death | 2 | 2018 | 392 | 0.250 |
Why?
| Internship and Residency | 2 | 2019 | 1045 | 0.240 |
Why?
| Risk Assessment | 7 | 2018 | 3232 | 0.240 |
Why?
| Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| Colorado | 7 | 2017 | 4399 | 0.240 |
Why?
| Bone and Bones | 2 | 2019 | 298 | 0.240 |
Why?
| Environment | 2 | 2017 | 345 | 0.240 |
Why?
| Schools, Medical | 1 | 2006 | 130 | 0.240 |
Why?
| Perinatal Care | 2 | 2018 | 54 | 0.240 |
Why?
| Feasibility Studies | 4 | 2023 | 863 | 0.230 |
Why?
| Retrospective Studies | 9 | 2023 | 14472 | 0.230 |
Why?
| Parents | 1 | 2013 | 1307 | 0.230 |
Why?
| Maternal Welfare | 2 | 2014 | 19 | 0.220 |
Why?
| Agaricus | 1 | 2023 | 2 | 0.220 |
Why?
| Erythrocytes | 5 | 2022 | 673 | 0.220 |
Why?
| China | 5 | 2014 | 190 | 0.220 |
Why?
| Asia | 6 | 2020 | 58 | 0.220 |
Why?
| Reference Values | 4 | 2022 | 780 | 0.210 |
Why?
| Ferritins | 2 | 2016 | 58 | 0.210 |
Why?
| Folic Acid Deficiency | 1 | 2023 | 48 | 0.210 |
Why?
| Milk | 3 | 2018 | 119 | 0.210 |
Why?
| Pandemics | 4 | 2024 | 1477 | 0.210 |
Why?
| Soybean Proteins | 1 | 2002 | 14 | 0.210 |
Why?
| Vitamin K | 1 | 2023 | 40 | 0.210 |
Why?
| Food Assistance | 1 | 2023 | 29 | 0.200 |
Why?
| Vitamin A | 1 | 2023 | 55 | 0.200 |
Why?
| Dietary Fats, Unsaturated | 1 | 2002 | 23 | 0.200 |
Why?
| Plant Oils | 1 | 2002 | 29 | 0.200 |
Why?
| Faculty, Medical | 1 | 2006 | 263 | 0.200 |
Why?
| Labor Presentation | 2 | 2019 | 2 | 0.200 |
Why?
| Parenteral Nutrition | 1 | 2024 | 104 | 0.200 |
Why?
| Temperature | 2 | 2023 | 632 | 0.200 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2023 | 101 | 0.200 |
Why?
| Infant Care | 2 | 2015 | 46 | 0.200 |
Why?
| Health Facilities | 2 | 2020 | 80 | 0.200 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2020 | 564 | 0.200 |
Why?
| Oryza | 1 | 2022 | 31 | 0.200 |
Why?
| United States | 14 | 2023 | 13840 | 0.200 |
Why?
| Dose-Response Relationship, Drug | 6 | 2019 | 1951 | 0.200 |
Why?
| Midwifery | 3 | 2014 | 48 | 0.200 |
Why?
| Puerperal Infection | 3 | 2024 | 5 | 0.200 |
Why?
| Fatty Acids | 3 | 2022 | 417 | 0.190 |
Why?
| Biomedical Research | 3 | 2017 | 633 | 0.190 |
Why?
| Enteral Nutrition | 1 | 2024 | 186 | 0.190 |
Why?
| Postnatal Care | 2 | 2020 | 71 | 0.190 |
Why?
| Africa | 5 | 2023 | 99 | 0.190 |
Why?
| Students | 1 | 2007 | 570 | 0.190 |
Why?
| Adolescent Health | 2 | 2019 | 39 | 0.190 |
Why?
| Adrenal Cortex Hormones | 2 | 2016 | 518 | 0.190 |
Why?
| Intestinal Diseases | 1 | 2022 | 35 | 0.190 |
Why?
| Rural Health | 5 | 2016 | 70 | 0.190 |
Why?
| Zinc Oxide | 3 | 2012 | 9 | 0.190 |
Why?
| Tobacco, Smokeless | 1 | 2021 | 10 | 0.190 |
Why?
| Patient Dropouts | 2 | 2012 | 64 | 0.190 |
Why?
| Bone Density | 3 | 2006 | 474 | 0.190 |
Why?
| Public Health | 3 | 2020 | 482 | 0.190 |
Why?
| Tablets | 4 | 2022 | 35 | 0.180 |
Why?
| Cystic Fibrosis | 3 | 2000 | 1049 | 0.180 |
Why?
| Iodine | 1 | 2021 | 24 | 0.180 |
Why?
| Amino Acids, Essential | 1 | 2021 | 13 | 0.180 |
Why?
| Isoleucine | 1 | 2021 | 14 | 0.180 |
Why?
| Treatment Outcome | 5 | 2018 | 10162 | 0.180 |
Why?
| Animals | 16 | 2025 | 34647 | 0.180 |
Why?
| Birth Rate | 1 | 2020 | 25 | 0.180 |
Why?
| Selenoproteins | 1 | 2020 | 7 | 0.180 |
Why?
| Surveys and Questionnaires | 7 | 2020 | 5371 | 0.180 |
Why?
| Phenylalanine | 1 | 2021 | 65 | 0.180 |
Why?
| Valine | 1 | 2021 | 81 | 0.170 |
Why?
| Carnitine | 1 | 2021 | 76 | 0.170 |
Why?
| Digestive System Physiological Phenomena | 1 | 2000 | 4 | 0.170 |
Why?
| Hyperinsulinism | 1 | 2021 | 119 | 0.170 |
Why?
| Leucine | 1 | 2021 | 108 | 0.170 |
Why?
| Cleft Lip | 1 | 2020 | 44 | 0.170 |
Why?
| Parturition | 1 | 2021 | 70 | 0.170 |
Why?
| Quality of Health Care | 3 | 2020 | 606 | 0.170 |
Why?
| Oligohydramnios | 1 | 2020 | 11 | 0.170 |
Why?
| Cleft Palate | 1 | 2020 | 58 | 0.170 |
Why?
| Spouses | 1 | 2021 | 99 | 0.170 |
Why?
| Biotransformation | 1 | 2020 | 48 | 0.170 |
Why?
| Endotoxemia | 1 | 2020 | 83 | 0.170 |
Why?
| Pasteurization | 1 | 2019 | 1 | 0.170 |
Why?
| Linear Models | 4 | 2016 | 816 | 0.170 |
Why?
| Digestion | 2 | 2017 | 9 | 0.170 |
Why?
| International Classification of Diseases | 1 | 2020 | 122 | 0.170 |
Why?
| Liver | 6 | 2020 | 1827 | 0.170 |
Why?
| Thinness | 2 | 2018 | 89 | 0.160 |
Why?
| Latin America | 5 | 2018 | 86 | 0.160 |
Why?
| Pilot Projects | 3 | 2023 | 1568 | 0.160 |
Why?
| Lactulose | 1 | 2019 | 1 | 0.160 |
Why?
| Diet, Fat-Restricted | 1 | 2000 | 80 | 0.160 |
Why?
| Health Resources | 1 | 2020 | 113 | 0.160 |
Why?
| Anemia, Sickle Cell | 1 | 2023 | 254 | 0.160 |
Why?
| Polyhydramnios | 1 | 2019 | 17 | 0.160 |
Why?
| Calorimetry | 1 | 2019 | 64 | 0.160 |
Why?
| Mannitol | 1 | 2019 | 35 | 0.160 |
Why?
| Intestines | 3 | 2019 | 344 | 0.160 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 167 | 0.160 |
Why?
| Cholesterol, HDL | 2 | 2023 | 203 | 0.160 |
Why?
| Hepcidins | 1 | 2019 | 22 | 0.160 |
Why?
| Endemic Diseases | 1 | 2019 | 31 | 0.160 |
Why?
| Hypersensitivity, Immediate | 1 | 2019 | 43 | 0.150 |
Why?
| Exercise | 7 | 2023 | 1918 | 0.150 |
Why?
| Malawi | 4 | 2015 | 48 | 0.150 |
Why?
| Beverages | 4 | 2019 | 67 | 0.150 |
Why?
| Oxidative Stress | 2 | 2017 | 1191 | 0.150 |
Why?
| Species Specificity | 1 | 2020 | 569 | 0.150 |
Why?
| Ghrelin | 1 | 2018 | 33 | 0.150 |
Why?
| Interdisciplinary Communication | 1 | 2019 | 185 | 0.150 |
Why?
| Postoperative Complications | 2 | 2009 | 2462 | 0.150 |
Why?
| Glucose | 3 | 2023 | 983 | 0.150 |
Why?
| Blood Urea Nitrogen | 1 | 2018 | 53 | 0.150 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 39 | 0.150 |
Why?
| Adolescent Development | 1 | 2019 | 84 | 0.150 |
Why?
| Middle Aged | 9 | 2025 | 30923 | 0.150 |
Why?
| Meat Products | 2 | 2012 | 25 | 0.150 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2021 | 382 | 0.150 |
Why?
| Erythrocyte Indices | 2 | 2021 | 27 | 0.150 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2020 | 488 | 0.150 |
Why?
| Clostridium | 1 | 2017 | 14 | 0.140 |
Why?
| Proteobacteria | 1 | 2017 | 15 | 0.140 |
Why?
| Bifidobacterium | 1 | 2017 | 21 | 0.140 |
Why?
| Food Supply | 1 | 2018 | 72 | 0.140 |
Why?
| Cluster Analysis | 5 | 2019 | 479 | 0.140 |
Why?
| Indians, Central American | 1 | 2017 | 5 | 0.140 |
Why?
| Social Determinants of Health | 1 | 2020 | 221 | 0.140 |
Why?
| Head | 2 | 2010 | 96 | 0.140 |
Why?
| Communication | 1 | 2023 | 841 | 0.140 |
Why?
| Infusions, Intravenous | 3 | 2006 | 394 | 0.140 |
Why?
| Zika Virus Infection | 1 | 2019 | 155 | 0.140 |
Why?
| Appetite | 2 | 2010 | 56 | 0.140 |
Why?
| Vaccines | 1 | 2022 | 396 | 0.140 |
Why?
| Isotopes | 1 | 2017 | 28 | 0.140 |
Why?
| Guidelines as Topic | 1 | 2019 | 260 | 0.140 |
Why?
| Copper | 3 | 2004 | 107 | 0.130 |
Why?
| Food Analysis | 2 | 2015 | 22 | 0.130 |
Why?
| Professional-Family Relations | 1 | 2018 | 144 | 0.130 |
Why?
| Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.130 |
Why?
| Africa South of the Sahara | 4 | 2018 | 41 | 0.130 |
Why?
| Gene Expression | 1 | 2021 | 1455 | 0.130 |
Why?
| Biomedical Technology | 1 | 2017 | 40 | 0.130 |
Why?
| Dietary Sucrose | 1 | 2016 | 48 | 0.130 |
Why?
| Population Surveillance | 4 | 2020 | 435 | 0.130 |
Why?
| Intensive Care, Neonatal | 1 | 2016 | 39 | 0.130 |
Why?
| Interleukin-8 | 1 | 2017 | 262 | 0.130 |
Why?
| Fatty Acids, Unsaturated | 1 | 2016 | 95 | 0.130 |
Why?
| Down-Regulation | 1 | 2018 | 632 | 0.130 |
Why?
| Blood Pressure | 2 | 2020 | 1712 | 0.130 |
Why?
| Spectrophotometry, Atomic | 8 | 2013 | 13 | 0.120 |
Why?
| Reproducibility of Results | 3 | 2020 | 3021 | 0.120 |
Why?
| Ethiopia | 4 | 2009 | 35 | 0.120 |
Why?
| Insulin Resistance | 2 | 2021 | 1164 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2016 | 138 | 0.120 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 258 | 0.120 |
Why?
| Vitamin B 12 | 2 | 2023 | 122 | 0.120 |
Why?
| Diabetes Mellitus | 4 | 2016 | 996 | 0.120 |
Why?
| Overnutrition | 1 | 2015 | 30 | 0.120 |
Why?
| American Heart Association | 1 | 2016 | 297 | 0.120 |
Why?
| Data Accuracy | 1 | 2015 | 57 | 0.120 |
Why?
| Haemophilus influenzae type b | 1 | 2014 | 10 | 0.120 |
Why?
| Bacterial Capsules | 1 | 2014 | 28 | 0.120 |
Why?
| Stroke | 1 | 2023 | 1073 | 0.120 |
Why?
| Risk Reduction Behavior | 1 | 2016 | 208 | 0.120 |
Why?
| Haemophilus Vaccines | 1 | 2014 | 28 | 0.120 |
Why?
| Antibody Affinity | 1 | 2014 | 59 | 0.110 |
Why?
| World Health Organization | 3 | 2012 | 110 | 0.110 |
Why?
| Drug Utilization | 3 | 2024 | 169 | 0.110 |
Why?
| Placenta | 1 | 2021 | 719 | 0.110 |
Why?
| Multivariate Analysis | 5 | 2020 | 1499 | 0.110 |
Why?
| Chile | 2 | 2012 | 20 | 0.110 |
Why?
| Pregnancy in Adolescence | 1 | 2015 | 81 | 0.110 |
Why?
| Contraception Behavior | 1 | 2015 | 97 | 0.110 |
Why?
| Algorithms | 3 | 2017 | 1614 | 0.110 |
Why?
| Pneumonia | 2 | 1999 | 601 | 0.110 |
Why?
| Life Style | 2 | 2015 | 459 | 0.110 |
Why?
| Sequence Analysis, DNA | 1 | 2017 | 775 | 0.110 |
Why?
| Cost-Benefit Analysis | 3 | 2025 | 569 | 0.110 |
Why?
| Health Services Accessibility | 2 | 2019 | 901 | 0.110 |
Why?
| Qualitative Research | 1 | 2021 | 1227 | 0.110 |
Why?
| Family Planning Services | 1 | 2015 | 88 | 0.110 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 335 | 0.110 |
Why?
| Bacterial Infections | 1 | 2016 | 235 | 0.110 |
Why?
| Up-Regulation | 1 | 2017 | 823 | 0.110 |
Why?
| Food Preferences | 1 | 2015 | 113 | 0.110 |
Why?
| Antibodies, Bacterial | 1 | 2014 | 137 | 0.110 |
Why?
| Pennisetum | 1 | 2013 | 1 | 0.110 |
Why?
| Hair | 3 | 2011 | 73 | 0.110 |
Why?
| Acrodermatitis | 1 | 2013 | 1 | 0.110 |
Why?
| Needs Assessment | 2 | 2015 | 356 | 0.110 |
Why?
| Alkaline Phosphatase | 3 | 2011 | 142 | 0.110 |
Why?
| Neonatology | 1 | 2013 | 22 | 0.110 |
Why?
| Population Groups | 1 | 2013 | 58 | 0.110 |
Why?
| Pregnancy, Multiple | 1 | 2013 | 15 | 0.110 |
Why?
| Health Services Needs and Demand | 1 | 2015 | 262 | 0.100 |
Why?
| Liver Diseases | 3 | 2013 | 287 | 0.100 |
Why?
| Escherichia coli | 1 | 2017 | 771 | 0.100 |
Why?
| Puerperal Disorders | 3 | 2020 | 30 | 0.100 |
Why?
| Indicator Dilution Techniques | 4 | 2006 | 11 | 0.100 |
Why?
| Iron Radioisotopes | 1 | 2012 | 4 | 0.100 |
Why?
| Fetal Growth Retardation | 3 | 2025 | 543 | 0.100 |
Why?
| Prolactin | 2 | 2007 | 99 | 0.100 |
Why?
| Poverty Areas | 1 | 2012 | 35 | 0.100 |
Why?
| Leukocyte L1 Antigen Complex | 1 | 2012 | 29 | 0.100 |
Why?
| Endocrine System | 1 | 2012 | 20 | 0.100 |
Why?
| Urban Health | 1 | 2012 | 79 | 0.100 |
Why?
| Clinical Competence | 1 | 2019 | 1009 | 0.100 |
Why?
| Child Development Disorders, Pervasive | 1 | 2012 | 61 | 0.100 |
Why?
| Hospitals, University | 1 | 2012 | 176 | 0.100 |
Why?
| Triglycerides | 1 | 2014 | 523 | 0.100 |
Why?
| Mammary Glands, Human | 1 | 2012 | 64 | 0.100 |
Why?
| Intestine, Small | 2 | 2011 | 145 | 0.090 |
Why?
| Obstetrics | 1 | 2013 | 161 | 0.090 |
Why?
| Cerebrovascular Disorders | 1 | 2012 | 90 | 0.090 |
Why?
| Analysis of Variance | 3 | 2002 | 1273 | 0.090 |
Why?
| Curriculum | 3 | 2019 | 910 | 0.090 |
Why?
| Morphogenesis | 1 | 2012 | 156 | 0.090 |
Why?
| Erythrocyte Membrane | 1 | 2011 | 49 | 0.090 |
Why?
| Incidence | 4 | 2019 | 2638 | 0.090 |
Why?
| Chickens | 1 | 2011 | 187 | 0.090 |
Why?
| International Agencies | 1 | 2011 | 29 | 0.090 |
Why?
| Spectrometry, Mass, Fast Atom Bombardment | 4 | 1998 | 6 | 0.090 |
Why?
| Digestive System | 2 | 2001 | 29 | 0.090 |
Why?
| Single-Blind Method | 1 | 2011 | 268 | 0.090 |
Why?
| Growth Charts | 1 | 2010 | 14 | 0.090 |
Why?
| Interviews as Topic | 1 | 2014 | 715 | 0.090 |
Why?
| Interleukin-6 | 1 | 2014 | 715 | 0.090 |
Why?
| Language | 1 | 2013 | 280 | 0.090 |
Why?
| Inositol Phosphates | 1 | 2010 | 22 | 0.090 |
Why?
| Dexamethasone | 1 | 2012 | 345 | 0.080 |
Why?
| Food, Formulated | 1 | 1989 | 14 | 0.080 |
Why?
| Argentina | 3 | 2014 | 15 | 0.080 |
Why?
| Physicians | 2 | 2019 | 863 | 0.080 |
Why?
| Child Welfare | 1 | 2012 | 211 | 0.080 |
Why?
| Family Nursing | 1 | 2009 | 13 | 0.080 |
Why?
| Manganese | 1 | 1989 | 60 | 0.080 |
Why?
| Public Assistance | 1 | 2009 | 21 | 0.080 |
Why?
| Blood Glucose | 2 | 2021 | 2092 | 0.080 |
Why?
| Program Evaluation | 1 | 2014 | 872 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1187 | 0.080 |
Why?
| Mexico | 1 | 2009 | 190 | 0.080 |
Why?
| Patient Acceptance of Health Care | 1 | 2015 | 757 | 0.080 |
Why?
| Ascorbic Acid | 1 | 2009 | 119 | 0.080 |
Why?
| Cattle | 2 | 2024 | 965 | 0.080 |
Why?
| Patient Compliance | 1 | 2012 | 560 | 0.070 |
Why?
| Celiac Disease | 1 | 2011 | 286 | 0.070 |
Why?
| Hospitals, Pediatric | 1 | 2012 | 509 | 0.070 |
Why?
| Congo | 2 | 2020 | 4 | 0.070 |
Why?
| Urban Population | 3 | 2018 | 441 | 0.070 |
Why?
| Safety | 1 | 2010 | 328 | 0.070 |
Why?
| Health Planning Guidelines | 1 | 2007 | 24 | 0.070 |
Why?
| Disease Management | 1 | 2012 | 584 | 0.070 |
Why?
| Food Handling | 2 | 2025 | 60 | 0.070 |
Why?
| Nutrition Disorders | 1 | 2007 | 23 | 0.070 |
Why?
| Cognition | 2 | 2009 | 1110 | 0.070 |
Why?
| Fatty Acids, Volatile | 2 | 2018 | 57 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2021 | 2433 | 0.070 |
Why?
| Child Behavior | 1 | 2009 | 235 | 0.070 |
Why?
| Combined Modality Therapy | 1 | 2010 | 1201 | 0.070 |
Why?
| Aged | 3 | 2023 | 21976 | 0.070 |
Why?
| Mutation | 2 | 2013 | 3696 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2009 | 1817 | 0.070 |
Why?
| Sex Factors | 2 | 2010 | 1951 | 0.070 |
Why?
| Research Design | 2 | 2019 | 1036 | 0.070 |
Why?
| Carrier Proteins | 2 | 2002 | 732 | 0.070 |
Why?
| Injections, Intravenous | 3 | 2004 | 197 | 0.070 |
Why?
| Caregivers | 1 | 2014 | 813 | 0.070 |
Why?
| Proteins | 1 | 2012 | 936 | 0.060 |
Why?
| Sex Characteristics | 1 | 2011 | 722 | 0.060 |
Why?
| Postprandial Period | 2 | 1997 | 103 | 0.060 |
Why?
| Problem-Based Learning | 1 | 2006 | 77 | 0.060 |
Why?
| Isomerism | 1 | 2025 | 48 | 0.060 |
Why?
| Energy Metabolism | 2 | 2015 | 833 | 0.060 |
Why?
| Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| Malaria, Falciparum | 1 | 2005 | 26 | 0.060 |
Why?
| Education, Medical, Continuing | 1 | 2006 | 121 | 0.060 |
Why?
| Obstetric Labor, Premature | 2 | 2016 | 35 | 0.060 |
Why?
| Gastroplasty | 1 | 2004 | 29 | 0.060 |
Why?
| Health Behavior | 2 | 2023 | 740 | 0.060 |
Why?
| Schools | 1 | 2007 | 436 | 0.050 |
Why?
| Delivery of Health Care | 2 | 2022 | 889 | 0.050 |
Why?
| Zinc Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
| Mice, Inbred C57BL | 3 | 2020 | 5281 | 0.050 |
Why?
| Hydroxyurea | 1 | 2023 | 33 | 0.050 |
Why?
| Home Childbirth | 2 | 2013 | 5 | 0.050 |
Why?
| Sodium Chloride, Dietary | 1 | 2023 | 28 | 0.050 |
Why?
| Neonatal Sepsis | 1 | 2023 | 3 | 0.050 |
Why?
| Palm Oil | 1 | 2002 | 2 | 0.050 |
Why?
| Ethers | 1 | 2022 | 16 | 0.050 |
Why?
| Sodium Chloride | 1 | 2023 | 138 | 0.050 |
Why?
| Phosphatidylethanolamines | 1 | 2022 | 74 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2023 | 286 | 0.050 |
Why?
| Docosahexaenoic Acids | 1 | 2022 | 83 | 0.050 |
Why?
| Reference Standards | 1 | 2002 | 170 | 0.050 |
Why?
| Genetic Engineering | 1 | 2002 | 88 | 0.050 |
Why?
| Cholesterol | 1 | 2023 | 406 | 0.050 |
Why?
| Community Health Services | 1 | 2023 | 227 | 0.050 |
Why?
| Circadian Rhythm | 1 | 1985 | 412 | 0.050 |
Why?
| Evidence-Based Medicine | 1 | 2005 | 712 | 0.040 |
Why?
| Phospholipids | 1 | 2022 | 207 | 0.040 |
Why?
| Central America | 1 | 2020 | 21 | 0.040 |
Why?
| Magnesium | 2 | 2001 | 151 | 0.040 |
Why?
| Animals, Newborn | 2 | 2014 | 808 | 0.040 |
Why?
| Glutathione Peroxidase | 1 | 2020 | 43 | 0.040 |
Why?
| Selenium | 1 | 2020 | 36 | 0.040 |
Why?
| Pregnancy Trimester, Second | 2 | 2019 | 77 | 0.040 |
Why?
| Orosomucoid | 1 | 2020 | 6 | 0.040 |
Why?
| Metallothionein | 1 | 2000 | 24 | 0.040 |
Why?
| Vaccination | 2 | 2022 | 1346 | 0.040 |
Why?
| Glucose Tolerance Test | 1 | 2021 | 356 | 0.040 |
Why?
| Child Abuse | 1 | 2005 | 517 | 0.040 |
Why?
| Licensure | 1 | 2019 | 12 | 0.040 |
Why?
| HIV Infections | 1 | 2014 | 2711 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2011 | 2719 | 0.040 |
Why?
| Nicaragua | 1 | 2019 | 7 | 0.040 |
Why?
| Zinc Sulfate | 2 | 2012 | 8 | 0.040 |
Why?
| Colombia | 1 | 2019 | 36 | 0.040 |
Why?
| Puerto Rico | 1 | 2019 | 52 | 0.040 |
Why?
| Peru | 1 | 2019 | 53 | 0.040 |
Why?
| Hepatocytes | 1 | 2020 | 213 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2022 | 428 | 0.040 |
Why?
| Accreditation | 1 | 2019 | 80 | 0.040 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 102 | 0.040 |
Why?
| Family Relations | 1 | 2000 | 88 | 0.040 |
Why?
| Brazil | 1 | 2019 | 154 | 0.040 |
Why?
| Term Birth | 1 | 2018 | 20 | 0.040 |
Why?
| Asia, Southeastern | 1 | 2018 | 11 | 0.040 |
Why?
| Amniotic Fluid | 1 | 2019 | 86 | 0.040 |
Why?
| Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| Least-Squares Analysis | 1 | 1998 | 72 | 0.040 |
Why?
| Rhinitis, Allergic | 1 | 2019 | 38 | 0.040 |
Why?
| Spleen | 1 | 2020 | 509 | 0.040 |
Why?
| Focus Groups | 1 | 2021 | 452 | 0.040 |
Why?
| Gene Expression Regulation | 2 | 2021 | 2516 | 0.040 |
Why?
| Eczema | 1 | 2019 | 67 | 0.040 |
Why?
| Organ Specificity | 2 | 2014 | 290 | 0.040 |
Why?
| Diet, Western | 1 | 2018 | 79 | 0.040 |
Why?
| Microwaves | 1 | 1998 | 35 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2019 | 272 | 0.040 |
Why?
| Zika Virus | 1 | 2019 | 118 | 0.040 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 278 | 0.040 |
Why?
| Odds Ratio | 1 | 2020 | 1019 | 0.040 |
Why?
| Hospitals, Maternity | 1 | 2017 | 4 | 0.040 |
Why?
| C-Reactive Protein | 1 | 2020 | 398 | 0.040 |
Why?
| Tuberculosis | 1 | 2000 | 272 | 0.030 |
Why?
| Food-Drug Interactions | 1 | 2017 | 8 | 0.030 |
Why?
| Pressure | 1 | 1998 | 237 | 0.030 |
Why?
| Bile Acids and Salts | 1 | 2018 | 194 | 0.030 |
Why?
| Dysbiosis | 1 | 2018 | 167 | 0.030 |
Why?
| Fermentation | 1 | 2017 | 26 | 0.030 |
Why?
| Health Care Surveys | 1 | 2019 | 558 | 0.030 |
Why?
| Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.030 |
Why?
| Chromatography, Gas | 1 | 2016 | 31 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2018 | 228 | 0.030 |
Why?
| Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| Kidney | 2 | 2020 | 1310 | 0.030 |
Why?
| Continuity of Patient Care | 1 | 2019 | 275 | 0.030 |
Why?
| Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 1997 | 248 | 0.030 |
Why?
| Phosphates | 1 | 1997 | 169 | 0.030 |
Why?
| Pyruvate Kinase | 1 | 2016 | 26 | 0.030 |
Why?
| Computer Simulation | 1 | 2000 | 939 | 0.030 |
Why?
| Food Hypersensitivity | 1 | 2019 | 173 | 0.030 |
Why?
| Community Health Centers | 1 | 2016 | 57 | 0.030 |
Why?
| Plethysmography | 1 | 2016 | 107 | 0.030 |
Why?
| RNA, Viral | 1 | 2019 | 615 | 0.030 |
Why?
| Drug Interactions | 1 | 2017 | 361 | 0.030 |
Why?
| Pancreas | 1 | 1998 | 306 | 0.030 |
Why?
| Reproductive Behavior | 1 | 2015 | 11 | 0.030 |
Why?
| Dermatitis, Atopic | 1 | 2019 | 319 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1938 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2019 | 601 | 0.030 |
Why?
| Students, Medical | 1 | 2019 | 315 | 0.030 |
Why?
| Dental Caries | 1 | 2016 | 156 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2022 | 1689 | 0.030 |
Why?
| Medical History Taking | 1 | 1995 | 116 | 0.030 |
Why?
| Absorption, Physiological | 1 | 2014 | 4 | 0.030 |
Why?
| Healthcare Disparities | 1 | 2020 | 579 | 0.030 |
Why?
| Vaccines, Conjugate | 1 | 2014 | 63 | 0.030 |
Why?
| Fetal Proteins | 1 | 1994 | 16 | 0.030 |
Why?
| Patient Care Planning | 1 | 2015 | 148 | 0.030 |
Why?
| Insulin-Like Growth Factor II | 1 | 1994 | 25 | 0.030 |
Why?
| Bacteria | 1 | 2020 | 817 | 0.030 |
Why?
| Kinetics | 3 | 2007 | 1624 | 0.030 |
Why?
| Ferrous Compounds | 2 | 2005 | 23 | 0.030 |
Why?
| Health | 1 | 2014 | 73 | 0.030 |
Why?
| Serum Albumin | 3 | 1999 | 146 | 0.030 |
Why?
| Estradiol | 1 | 1997 | 489 | 0.030 |
Why?
| Tissue Distribution | 1 | 2014 | 296 | 0.030 |
Why?
| Amino Acids | 1 | 1997 | 477 | 0.030 |
Why?
| Physical Examination | 1 | 1995 | 233 | 0.030 |
Why?
| Maternal-Fetal Exchange | 1 | 2014 | 161 | 0.030 |
Why?
| Contraception | 1 | 2015 | 153 | 0.030 |
Why?
| Uruguay | 1 | 2013 | 1 | 0.030 |
Why?
| Pregnancy, Twin | 1 | 2013 | 18 | 0.030 |
Why?
| Morbidity | 1 | 2014 | 301 | 0.030 |
Why?
| Hypertension | 2 | 2016 | 1236 | 0.030 |
Why?
| Fetal Mortality | 1 | 2012 | 2 | 0.030 |
Why?
| Fetal Membranes, Premature Rupture | 1 | 2012 | 36 | 0.020 |
Why?
| DNA Replication | 1 | 1994 | 225 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2017 | 1003 | 0.020 |
Why?
| Minerals | 1 | 2012 | 41 | 0.020 |
Why?
| South Australia | 1 | 2011 | 3 | 0.020 |
Why?
| Mammary Glands, Animal | 1 | 2012 | 124 | 0.020 |
Why?
| Healthy Volunteers | 1 | 2012 | 199 | 0.020 |
Why?
| Liver Transplantation | 1 | 1999 | 800 | 0.020 |
Why?
| Breath Tests | 1 | 2011 | 89 | 0.020 |
Why?
| Metabolic Diseases | 1 | 2012 | 104 | 0.020 |
Why?
| Clinical Protocols | 1 | 2012 | 254 | 0.020 |
Why?
| Sucrose | 1 | 2011 | 99 | 0.020 |
Why?
| Carbon Isotopes | 1 | 2011 | 123 | 0.020 |
Why?
| Risk | 1 | 2013 | 853 | 0.020 |
Why?
| Disease Susceptibility | 1 | 2012 | 332 | 0.020 |
Why?
| Health Surveys | 1 | 2012 | 493 | 0.020 |
Why?
| Models, Theoretical | 1 | 2012 | 542 | 0.020 |
Why?
| Lung | 1 | 2020 | 3748 | 0.020 |
Why?
| Biopsy | 1 | 2011 | 1079 | 0.020 |
Why?
| Protein Deficiency | 1 | 2007 | 3 | 0.020 |
Why?
| Counseling | 1 | 2010 | 384 | 0.020 |
Why?
| Blood Transfusion | 1 | 1989 | 295 | 0.020 |
Why?
| Self Efficacy | 1 | 2010 | 371 | 0.020 |
Why?
| Food, Genetically Modified | 1 | 2006 | 2 | 0.020 |
Why?
| Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 26 | 0.020 |
Why?
| Plants, Genetically Modified | 1 | 2006 | 15 | 0.020 |
Why?
| Sweat | 1 | 1986 | 46 | 0.020 |
Why?
| Biliary Atresia | 1 | 1987 | 161 | 0.020 |
Why?
| Asthma | 1 | 2019 | 2213 | 0.020 |
Why?
| Gallstones | 1 | 2005 | 31 | 0.010 |
Why?
| Antimalarials | 1 | 2005 | 30 | 0.010 |
Why?
| Chloroquine | 1 | 2005 | 52 | 0.010 |
Why?
| Placebos | 1 | 2005 | 201 | 0.010 |
Why?
| Isotope Labeling | 1 | 2005 | 73 | 0.010 |
Why?
| Mental Competency | 1 | 2004 | 27 | 0.010 |
Why?
| Parental Consent | 1 | 2004 | 25 | 0.010 |
Why?
| Anorexia | 1 | 1984 | 18 | 0.010 |
Why?
| Family Characteristics | 1 | 2005 | 178 | 0.010 |
Why?
| Primary Prevention | 1 | 2005 | 188 | 0.010 |
Why?
| Informed Consent | 1 | 2004 | 168 | 0.010 |
Why?
| Parent-Child Relations | 1 | 2005 | 256 | 0.010 |
Why?
| Models, Statistical | 1 | 2007 | 622 | 0.010 |
Why?
| Gastrointestinal Transit | 1 | 2002 | 6 | 0.010 |
Why?
| Body Fluid Compartments | 1 | 2002 | 6 | 0.010 |
Why?
| Mass Screening | 1 | 2010 | 1146 | 0.010 |
Why?
| Mice | 1 | 2018 | 16620 | 0.010 |
Why?
| Mental Recall | 1 | 2003 | 190 | 0.010 |
Why?
| Free Radicals | 1 | 2001 | 103 | 0.010 |
Why?
| Radioactive Tracers | 1 | 2000 | 3 | 0.010 |
Why?
| Gastric Mucosa | 1 | 2000 | 50 | 0.010 |
Why?
| Phosphorus | 1 | 2001 | 93 | 0.010 |
Why?
| Urine | 1 | 2000 | 56 | 0.010 |
Why?
| Patient Selection | 1 | 2004 | 661 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2012 | 7057 | 0.010 |
Why?
| Blood | 1 | 2000 | 100 | 0.010 |
Why?
| Diabetes Complications | 1 | 2001 | 223 | 0.010 |
Why?
| Patient Education as Topic | 1 | 2004 | 734 | 0.010 |
Why?
| Eating | 1 | 2000 | 369 | 0.010 |
Why?
| Postoperative Period | 1 | 1999 | 324 | 0.010 |
Why?
| Creatinine | 1 | 1999 | 480 | 0.010 |
Why?
| Acute Disease | 1 | 1999 | 965 | 0.010 |
Why?
| Software | 1 | 2000 | 608 | 0.010 |
Why?
| Europe | 1 | 1995 | 360 | 0.010 |
Why?
| North America | 1 | 1995 | 290 | 0.010 |
Why?
| Chronic Disease | 1 | 1999 | 1692 | 0.010 |
Why?
| Sheep | 1 | 1994 | 831 | 0.010 |
Why?
| Urinary Tract Infections | 1 | 1989 | 147 | 0.000 |
Why?
| Erythrocyte Transfusion | 1 | 1989 | 181 | 0.000 |
Why?
| RNA, Messenger | 1 | 1994 | 2679 | 0.000 |
Why?
| Cells, Cultured | 1 | 1994 | 4017 | 0.000 |
Why?
| Surgical Wound Infection | 1 | 1989 | 282 | 0.000 |
Why?
| Saliva | 1 | 1983 | 210 | 0.000 |
Why?
| Blood Proteins | 1 | 1983 | 240 | 0.000 |
Why?
|
|
Krebs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|